source
- FDA approves nivolumab plus AVD for untreated advanced-stage Hodgkin lymphomaDr. Alex Herrera, a professor and chief of lymphoma at City of Hope, highlighted the recent FDA clearance of the combination of nivolumab with the chemotherapy regimen AVD for patients with newly d…
- Novo Nordisk shares rise as Wegovy updates improve earnings outlookNovo Nordisk reported that recent data on its obesity drug Wegovy were less negative than expected, helping the company’s earnings. The improved outlook lifted Novo Nordisk’s share price, narrowin…